Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anthony D. Sercel is active.

Publication


Featured researches published by Anthony D. Sercel.


Synthetic Communications | 2007

Simple Synthesis of 4‐Substituted 1(2H)‐Isoquinolinones via Electrophilic Trapping of Lithiated Mono‐ and Dianion Precursors

Anthony D. Sercel; Joseph P. Sanchez; H. D. Hollis Showalter

Abstract Synthetic routes have been developed to access 4‐substituted 1(2H)‐isoquinolinones from readily available precursors. This is achieved via electrophilic trapping of di‐ and monolithium anions derived from alkyllithium exchange of 4‐bromo‐1(2H)‐isoquinolinones and corresponding 4‐bromo‐1‐methoxyisoquinolines, respectively. Products derived from the latter are then hydrolyzed to the target 4‐substituted 1(2H)‐isoquinolinones. The methodology has potential application to access 4‐substituted 1(2H)‐isoquinolinones with additional substituents in either ring.


Tetrahedron Letters | 2000

A simple method for preparation of N-mono- and N,N-di-alkylated α-amino acids

Yuntao Song; Anthony D. Sercel; Don Johnson; Norman L. Colbry; Kuai-Lin Sun; Bruce D. Roth

Abstract Reactions of α-amino acids with ketones under hydrogenation conditions using 20% Pd(OH) 2 /C as the catalyst gave N -mono-alkylated amino acids in high yields. Reductive methylation of N -mono-alkylated amino acids under the same hydrogenation conditions at 50°C afforded N , N -di-alkylated amino acids in excellent yields. This simple method has been used to synthesize N -mono- and N , N -di-alkylated amino acids on a scale of 200 g.


Journal of Medicinal Chemistry | 1999

Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series1

Yuntao Song; David T. Connor; Anthony D. Sercel; Roderick Joseph Sorenson; Robert Doubleday; Paul C. Unangst; Bruce David Roth; Vlad G. Beylin; Richard B. Gilbertsen; Kam Chan; Denis J. Schrier; Antonio Guglietta; Dirk A. Bornemeier; Richard D. Dyer


Tetrahedron Letters | 2004

Pyrrolo-dC and pyrrolo-C: fluorescent analogs of cytidine and 2′-deoxycytidine for the study of oligonucleotides

David A. Berry; Kee-Yong Jung; Dean S. Wise; Anthony D. Sercel; William H. Pearson; Hugh Mackie; John Randolph; Robert L. Somers


Journal of Organic Chemistry | 2005

Fluorous affinity purification of oligonucleotides

William H. Pearson; David A. Berry; Patrick Stoy; Kee-Yong Jung; Anthony D. Sercel


Journal of Medicinal Chemistry | 1992

Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.

Alan J. Kraker; James D. Hoeschele; William L. Elliott; H. D. Hollis Showalter; Anthony D. Sercel; Nicholas P. Farrell


Journal of Medicinal Chemistry | 1988

Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemias

H. D. Hollis Showalter; Mario M. Angelo; Ellen M. Berman; Gerald D. Kanter; Daniel F. Ortwine; Suzanne G. Ross-Kesten; Anthony D. Sercel; William Richard Turner; Leslie M. Werbel; Donald F. Worth; Edward F. Elslager; Wilbur R. Leopold; Joan L. Shillis


Journal of Medicinal Chemistry | 1995

Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinases.

Brian D. Palmer; Gordon W. Rewcastle; Andrew M. Thompson; Maruta Boyd; H. D. Hollis Showalter; Anthony D. Sercel; David W. Fry; Alan J. Kraker; William A. Denny


Archive | 2003

Fluorescent nitrogenous base and nucleosides incorporating same

Dean S. Wise; Anthony D. Sercel; Kee-Yong Jung; David A. Berry; John Randolph; Robert L. Somers; Hugh Mackie


Journal of Medicinal Chemistry | 1997

Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners

H. D. Hollis Showalter; Anthony D. Sercel; Boguslawa M. Leja; Craig D. Wolfangel; Linda A. Ambroso; William L. Elliott; David W. Fry; Alan J. Kraker; Curtis T. Howard; Gina H. Lu; Charles W. Moore; James M. Nelson; Bill J. Roberts; Patrick W. Vincent; William A. Denny; Andrew M. Thompson

Collaboration


Dive into the Anthony D. Sercel's collaboration.

Top Co-Authors

Avatar

David A. Berry

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Dean S. Wise

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Hugh Mackie

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Robert L. Somers

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge